These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 7062283)

  • 21. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro.
    Meltzer HY; Simonovic M; Gudelsky GA
    Eur J Pharmacol; 1983 Aug; 92(1-2):83-9. PubMed ID: 6628538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 23. The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs.
    Mokler DJ; Stoudt KW; Rech RH
    Pharmacol Biochem Behav; 1985 May; 22(5):677-82. PubMed ID: 3859879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
    Tonge SR; Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature.
    Dyer DC
    J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552
    [No Abstract]   [Full Text] [Related]  

  • 26. Quipazine-induced stimulus control in the rat.
    Winter JC
    Psychopharmacology (Berl); 1979 Feb; 60(3):265-9. PubMed ID: 108704
    [No Abstract]   [Full Text] [Related]  

  • 27. LSD as a discriminative stimulus: role of dorsal raphe nucleus.
    Minnema D; Krynock G; Young R; Glennon R; Rosecrans J
    Subst Alcohol Actions Misuse; 1980; 1(1):29-34. PubMed ID: 7323940
    [No Abstract]   [Full Text] [Related]  

  • 28. Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant.
    Dwoskin LP; Sparber SB
    J Pharmacol Exp Ther; 1983 Apr; 225(1):77-84. PubMed ID: 6834279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The discriminative stimulus properties of LSD: mechanisms of action.
    Kuhn DM; White FJ; Appel JB
    Neuropharmacology; 1978; 17(4-5):257-63. PubMed ID: 652138
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
    Schechter MD; Winter JC
    J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
    Maĭmets MO; Vasar EE; Nurk AM; Allikmets LKh
    Farmakol Toksikol; 1985; 48(2):15-8. PubMed ID: 3996566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.
    Gresch PJ; Barrett RJ; Sanders-Bush E; Smith RL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):662-9. PubMed ID: 17077317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus.
    Winter JC; Rabin RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):617-24. PubMed ID: 3211970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psilocybin-induced stimulus control in the rat.
    Winter JC; Rice KC; Amorosi DJ; Rabin RA
    Pharmacol Biochem Behav; 2007 Oct; 87(4):472-80. PubMed ID: 17688928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism of d-lysergic acid diethylamide and mescaline by 1-methyl-1, 2, 5, 6-tetrahydropyridine-N, N-diethyl-carboxamide (THPC).
    Dyer DC; Benington F; Morin RD
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):197-200. PubMed ID: 127560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.
    Palumbo PA; Winter JC
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1221-6. PubMed ID: 1475306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonism of the LSD cue by putative serotonin antagonists: relationship to inhibition of in vivo [3H]spiroperidol binding.
    Nielsen EB; Ginn SR; Cunningham KA; Appel JB
    Behav Brain Res; 1985 Aug; 16(2-3):171-6. PubMed ID: 2931089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist.
    Colpaert FC; Janssen PA
    Neuropharmacology; 1983 Aug; 22(8):993-1000. PubMed ID: 6604885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.